UNSPSC 51171653: Prucalopride succinate

This classification denotes a serotonin agonist with the molecular formula C18H26CLN3O3.C4H6O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4V2G75E1CK. European Medicines Agency schedules prucalopride succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB28850. The term prucalopride succinate is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule prucalopride succinate under HS 29349990 and SITC 51579.

As of Q4 2014, PRUCALOPRIDE SUCCINATE remains US FDA's Preferred Term for this commodity. SMILES: COCCCN1CCC(CC1)NC(=O)C2CC(C(C3C2OCC3)N)CL.C(CC(=O)O)C(=O)O.

UNSPSC 51171653 Prucalopride succinate is a Commodity code for a specific pharmaceutical active ingredient. State and local governments do not appear to be procuring prucalopride succinate directly under this code; instead, recent solicitations tag broader pharmaceutical procurement activities — generic multi-source drugs, OTC products, and drug-testing services — under related codes and categories. The issuing bodies include state health agencies, county criminal justice departments, and multistate cooperative purchasing alliances. Work solicited ranges from direct-to-manufacturer pharmacy programs and generic pharmaceutical supply contracts to offender specimen collection and drug testing services, which may involve screening panels that could include multiple active ingredients but do not target prucalopride succinate specifically.

Recent activity appears concentrated in Texas and Minnesota. The Texas Health and Human Services Commission posted a Request for Information in March 2026 to explore direct-to-manufacturer prescription programs with response due April 3, 2026. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026 and contract effectiveness July 1, 2026. Collin County, Texas posted an RFP on July 9, 2026 for offender specimen collection and drug testing services with proposals due July 23, 2026, estimating $600,000 annual value. The code shows minimal direct relevance to prucalopride succinate procurement; state and local pharmaceutical buying under related codes focuses on broad generic supply, cooperative purchasing vehicles, and laboratory testing services rather than single-ingredient specialty pharmaceuticals.